GPO Legislation Waits For March 15 Deadline; Masimo v. Tyco Opens In L.A.
This article was originally published in The Gray Sheet
Executive Summary
Senate Judiciary/Antitrust Subcommittee Chair Mike DeWine (R-Ohio) and Ranking Democrat Herb Kohl (Wis.) will consider GPO comments through March 15 in weighing potential changes to the "Medical Device Competition Act" for re-introduction this year
You may also be interested in...
Senate Antitrust/Judiciary Staffer Probes For “Teeth” In GPO Initiative
The GPO industry must define penalties for departing from self-imposed ethical standards if group purchasing organizations want to avoid legislation, Senate staffer Seth Bloom suggested May 17
Senate Antitrust/Judiciary Staffer Probes For “Teeth” In GPO Initiative
The GPO industry must define penalties for departing from self-imposed ethical standards if group purchasing organizations want to avoid legislation, Senate staffer Seth Bloom suggested May 17
GPOs May Spurn Anti-Competitive Contracts After Masimo v. Tyco – MDMA
Masimo believes its $420 mil. legal victory over Tyco will spur large manufacturers and GPOs to gradually alter their business practices, resulting in long-term cost savings for hospitals